PREMARKET ALERT: Orexigen Therapeutics (OREX)

Posted in General 
July 23rd, 2009

Orexigen Therapeutics Inc. (Nasdaq: OREX) shares are down more than 5 percent to $7.83 in premarket trading of more than 200,000 shares just after 8 a.m. Eastern. It is among the most active Nasdaq names this morning. The company after Wednesday’s session proposed a 9 million-share secondary offering of its common stock. — Mike Tarsala

Comments are closed